First Time Loading...

Vita 34 AG
XETRA:V3V

Watchlist Manager
Vita 34 AG Logo
Vita 34 AG
XETRA:V3V
Watchlist
Price: 5.15 EUR 6.4% Market Closed
Updated: Apr 27, 2024

Wall Street
Price Targets

V3V Price Targets Summary
Vita 34 AG

Wall Street analysts forecast V3V stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for V3V is 5.56 EUR with a low forecast of 5.35 EUR and a high forecast of 5.88 EUR.

Lowest
Price Target
5.35 EUR
4% Upside
Average
Price Target
5.56 EUR
8% Upside
Highest
Price Target
5.88 EUR
14% Upside
Vita 34 AG Competitors:
Price Targets
METROPOLIS
Metropolis Healthcare Ltd
7% Downside
MGP
Medica Group PLC
2% Downside
QIPT
Quipt Home Medical Corp
82% Upside
9860
Adicon Holdings Ltd
53% Upside
AIDX
Healwell Al Inc
11% Downside
2273
Gushengtang Holdings Ltd
46% Upside
LALPATHLAB
Dr. Lal PathLabs Ltd
5% Upside
6667
Mega Genomics Ltd
117% Upside

Revenue
Forecast

Revenue Estimate
Vita 34 AG

For the last 8 years the compound annual growth rate for Vita 34 AG's revenue is 22%. The projected CAGR for the next 4 years is 13%.

22%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vita 34 AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Vita 34 AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is V3V's stock price target?
Price Target
5.56 EUR

According to Wall Street analysts, the average 1-year price target for V3V is 5.56 EUR with a low forecast of 5.35 EUR and a high forecast of 5.88 EUR.

What is Vita 34 AG's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Vita 34 AG's revenue is 22%. The projected CAGR for the next 4 years is 13%.